“liver-cancer” Archives

Entry Author Date Location
HistoSonics Aims To Move Forward After Raising $8.5M, Naming New CEO 04/24/17 Detroit Ann Arbor
Houston’s TMCx Accelerator Debuts First Class of Device Startups 11/17/16 Texas
Inspyr Leaves San Antonio for California to Be Near Clinical Trials 10/12/16 Texas
After $70M Boston Scientific Deal, CeloNova CEO Heads to Nonprofit 09/19/16 Texas
Inspyr Seeks Clinical Partner for Cash After New Name, Exec Hires 08/09/16 Texas
GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer 02/03/16 Texas
Austin Cancer Drugs Developer Mirna Therapeutics Files for an IPO 08/24/15 Texas
Six Takeaways From “New York’s Life Science Disruptors” 03/16/15 New York
Mirna Therapeutics Taking on Cancer With Help of Tiny RNAs 07/09/13 Texas
Isis Execs Upbeat as AstraZeneca Expands Cancer Drug Collaboration 06/05/13 San Diego
Celsion Liver Cancer Trial Fails to Meet Goals, Stock Plunges 01/31/13 New York
Light Sciences Oncology Stumbles in Clinical Trial, Layoffs Loom 10/04/11 Seattle
Delcath Takes FDA Hassle in Stride, Prepares to Sell New Chemo Device Overseas 08/17/11 New York
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News 04/28/11 San Diego
Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles 03/18/11 Boston
Jennerex, Maker of Cancer-Fighting Virus, Says Early Data Shows Survival Benefit 02/17/11 San Francisco
Alnylam CEO John Maraganore On Corporate Near-Termism, and Restoring Faith in RNAi 12/06/10 Boston
Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal 10/21/10 Boston
Jennerex, Charging Ahead With Tumor-Killing Virus, Follows Biotech Road Less Traveled 09/09/10 San Francisco
Light Sciences Oncology Sits Tight, Awaits Key Cancer Trial Results This Summer 03/01/10 Seattle
Merck’s Alan Sachs, on RNAi’s Big Challenge: Delivery, Delivery, Delivery 01/21/10 National
Alnylam, Studying History of Genzyme, Eyes Drug to Make Big Impact for Rare Disease 12/14/09 Boston
Light Sciences Oncology Lines Up Extra $35M Financing For Targeted Cancer Treatment 11/05/09 Seattle
Brown U. and Johns Hopkins Researchers Form Sentient Bioscience to Improve Liver Cancer Treatment 09/15/09 Boston
Light Sciences Starts BPH Trial 08/18/09 Seattle
Light Sciences Oncology, Led by CEO on the Go, Prepares for Its Big Day 07/24/08 Seattle
Light Sciences Oncology Raises $40 Million for Cancer Trials 07/15/08 Seattle
Page 1 of 1